XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Common stock, balance at beginning of period (in shares) at Dec. 31, 2021   221,913,559      
Balance at beginning of period at Dec. 31, 2021 $ 673,976 $ 222 $ 717,369 $ (43,560) $ (55)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 23,504     23,504  
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax (in shares)   10,387      
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax (1,328)   (1,328)    
Forfeiture of unvested common stock and dividend equivalents (in shares)   (114,332)      
Forfeiture of unvested common stock and dividend equivalents 0        
Stock-based compensation 10,500   10,500    
Compensatory units repurchased (14)   (14)    
Other comprehensive income (loss) (12)       (12)
Common stock, balance at end of period (in shares) at Mar. 31, 2022   221,809,614      
Balance at end of period at Mar. 31, 2022 706,626 $ 222 726,527 (20,056) (67)
Common stock, balance at beginning of period (in shares) at Dec. 31, 2022   219,656,587      
Balance at beginning of period at Dec. 31, 2022 672,735 $ 220 672,990 0 (475)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 9,099     9,099  
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax (in shares)   43,671      
Issuance of common stock upon vesting or exercise of stock-based awards, net of withholding tax (169)   (169)    
Forfeiture of unvested common stock and dividend equivalents (in shares)   (103,906)      
Forfeiture of unvested common stock and dividend equivalents 275   275    
Repurchase of common stock (in shares)   (346,699)      
Repurchase of common stock (3,244) $ (1) (3,243)    
Dividend equivalents issued 4,366        
Stock-based compensation 10,895   10,895    
Other comprehensive income (loss) 206       206
Common stock, balance at end of period (in shares) at Mar. 31, 2023   219,249,653      
Balance at end of period at Mar. 31, 2023 $ 694,163 $ 219 $ 685,114 $ 9,099 $ (269)